1Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespanREVIEWS1309-1312
2Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous systemREVIEWS1313-1321
5Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's diseaseREVIEWS1332-1337
6Targeting the mitochondrial permeability transition pore in traumatic central nervous system injuryREVIEWS1338-1341
7Current surgical treatments for Parkinson's disease and potential therapeutic targetsREVIEWS1342-1345
9Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration:neurophysiological insights into stem progenitor cell neurogenesis within a host environmentPERSPECTIVES1350-1351
11Exercise and hippocampal neurogenesis: a dogma re-examined and lessons learnedPERSPECTIVES1354-1355
12Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disordersPERSPECTIVES1356-1357
14Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid βPERSPECTIVES1360-1361
15Gamma-aminobutyric acid A receptors in Alzheimer's disease:highly localized remodeling of a complex and diverse signaling pathwayPERSPECTIVES1362-1363
16Factors contributing to clinical picture and progression of Huntington's diseasePERSPECTIVES1364-1365
18Advanced glycation end products induce neural tube defects through elevating oxidative stress in miceRESEARCH ARTICLES1368-1374
19Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synucleinRESEARCH ARTICLES1375-1383
20Effects of repetitive transcranial magnetic stimulation on cognitive function and cholinergic activity in the rat hippocampus after vascular dementiaRESEARCH ARTICLES1384-1389
